Osteoarthritis

OARSI initiative to develop classification criteria for early-stage symptomatic knee OA (early-stage symptomatic knee osteoarthritis (EsSKOA)): What conditions should be considered in the differential diagnosis of EsSKOA?

Osteoarthritis CartilagePublished Cross-sectional study

Authors' conclusion

The differential diagnosis for EsSKOA in adults presenting with undiagnosed knee symptoms includes symptomatic established radiographic knee OA, patellofemoral pain syndrome, meniscal and collateral ligament injuries, and immune-mediated and crystal-induced inflammatory arthritis.

Study context

Population
Clinicians consulting monthly on at least five people with undiagnosed knee symptoms7 clinical disciplines
Participants
127 clinicians
Outcome
Conditions considered in the differential diagnosis of EsSKOA and among the top three diagnoses for each case scenario
Methodological detailsonline survey of clinicians, case scenarios
  • Online survey of clinicians
  • Case scenarios

Main finding

As reported in the abstract

Top three conditions in the differential diagnosis
  • Knee OA and meniscal injuries among the top three conditions for all three scenarios
  • Scenario 1 (40-year-old, 1 month knee stiffness and swelling): followed by immune-mediated and crystal-induced inflammatory arthritis
  • Scenario 2 (50-year-old, 8 months knee discomfort while walking): followed by patellofemoral pain syndrome
  • Scenario 3 (60-year-old, intense knee discomfort getting out of a car 1 week ago): followed by collateral ligament injuries

Observational data: associations, not effects.

Original publication

OARSI initiative to develop classification criteria for early-stage symptomatic knee OA (EsSKOA): What conditions should be considered in the differential diagnosis of EsSKOA? Osteoarthritis Cartilage. Published 23 May 2025. doi:10.1016/j.joca.2025.05.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.